Innovent Biologics1801 
$5.63-0.79%24h
-0.79%24h
Global rank1710
Market cap$9.06B
Change 7d-0.34%
YTD Performance3.18%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Market capitalization of Innovent Biologics (1801)
As of November 2024, Innovent Biologics has a market cap of $9.06B. This makes Innovent Biologics the world's 1710th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Innovent Biologics from 2018 to 2024
-
Value:-
Market cap history of Innovent Biologics from 2018 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $7.71B | -12.75% |
| 2023 | $8.83B | 27.61% |
| 2022 | $6.92B | -30.57% |
| 2021 | $9.97B | -41.73% |
| 2020 | $17.11B | 211.86% |
| 2019 | $5.49B | 10.17% |
| 2018 | $4.98B | - |
1801 Market Cap Today is $9.06B -0.79% - 21 Nov 2024
View largest stocks by market cap 
